| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 BCL9L NCOA3 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A MAML3 EP300 | 1.81e-10 | 303 | 50 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 BCL9L NCOA3 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A MAML3 EP300 | 1.10e-07 | 562 | 50 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | nucleosome binding | 4.57e-06 | 98 | 50 | 5 | GO:0031491 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L NCOA3 ARID1B KSR2 SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A MAML3 EP300 | 2.16e-05 | 1160 | 50 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 7.64e-05 | 33 | 50 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | chromatin binding | 7.96e-05 | 739 | 50 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L NCOA3 ARID1B KSR2 SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A MAML3 EP300 | 9.91e-05 | 1356 | 50 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.03e-04 | 187 | 50 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 3.33e-04 | 11 | 50 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 4.71e-04 | 13 | 50 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 6.32e-04 | 67 | 50 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.05e-04 | 167 | 50 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.13e-03 | 20 | 50 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.25e-03 | 21 | 50 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 1.50e-03 | 23 | 50 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.73e-03 | 31 | 50 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.28e-03 | 34 | 50 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.38e-03 | 120 | 50 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.80e-03 | 417 | 50 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.87e-03 | 37 | 50 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.24e-03 | 51 | 50 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 7.81e-03 | 53 | 50 | 2 | GO:0016879 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 7.81e-03 | 53 | 50 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 8.38e-03 | 55 | 50 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.38e-03 | 55 | 50 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | ligase activity | 9.44e-03 | 174 | 50 | 3 | GO:0016874 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 9.91e-03 | 60 | 50 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.02e-02 | 61 | 50 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 1.06e-02 | 62 | 50 | 2 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 1.06e-02 | 62 | 50 | 2 | GO:0050661 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.09e-02 | 63 | 50 | 2 | GO:0030276 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 7.75e-09 | 29 | 50 | 5 | GO:2000819 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 3.66e-08 | 136 | 50 | 7 | GO:0045445 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 5.42e-08 | 42 | 50 | 5 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 6.89e-08 | 44 | 50 | 5 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.97e-07 | 54 | 50 | 5 | GO:0045663 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 2.16e-07 | 22 | 50 | 4 | GO:0006337 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 3.13e-07 | 24 | 50 | 4 | GO:0032986 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.29e-06 | 144 | 50 | 6 | GO:0045582 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 2.30e-06 | 88 | 50 | 5 | GO:0006289 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.55e-06 | 162 | 50 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 2.86e-06 | 92 | 50 | 5 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 3.35e-06 | 95 | 50 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.35e-06 | 95 | 50 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 3.91e-06 | 98 | 50 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 4.32e-06 | 100 | 50 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 4.99e-06 | 103 | 50 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 7.02e-06 | 51 | 50 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 7.20e-06 | 111 | 50 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 9.09e-06 | 202 | 50 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.72e-05 | 226 | 50 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.85e-05 | 65 | 50 | 4 | GO:0045815 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.93e-05 | 136 | 50 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.95e-05 | 231 | 50 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 2.15e-05 | 139 | 50 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 2.22e-05 | 68 | 50 | 4 | GO:0141137 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 2.25e-05 | 237 | 50 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.36e-05 | 239 | 50 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.46e-05 | 143 | 50 | 5 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 2.53e-05 | 242 | 50 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 2.53e-05 | 242 | 50 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 2.53e-05 | 242 | 50 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.65e-05 | 244 | 50 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 2.72e-05 | 146 | 50 | 5 | GO:2000779 | |
| GeneOntologyBiologicalProcess | muscle structure development | BCL9L ARID1B ATG7 VWA5A SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 3.33e-05 | 858 | 50 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.62e-05 | 155 | 50 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 3.82e-05 | 78 | 50 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 4.29e-05 | 266 | 50 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | NCOA2 NCOA3 ZNF536 ARID1B SRD5A1 SMARCA4 SMARCC1 ARID1A EP300 | 5.48e-05 | 727 | 50 | 9 | GO:0032870 |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 5.86e-05 | 87 | 50 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 6.93e-05 | 290 | 50 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 8.62e-05 | 186 | 50 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.13e-04 | 317 | 50 | 6 | GO:1903039 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.27e-04 | 324 | 50 | 6 | GO:0006302 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.63e-04 | 213 | 50 | 5 | GO:2000045 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 2.52e-04 | 234 | 50 | 5 | GO:0006282 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 2.57e-04 | 51 | 50 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 3.05e-04 | 540 | 50 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 3.06e-04 | 381 | 50 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 3.10e-04 | 382 | 50 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | RNA polymerase I preinitiation complex assembly | 3.12e-04 | 11 | 50 | 2 | GO:0001188 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 3.17e-04 | 246 | 50 | 5 | GO:1902806 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 3.23e-04 | 385 | 50 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 3.41e-04 | 389 | 50 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BCL9L NCOA3 ARID1B EIF4G2 SMARCA4 SMARCC1 SMARCD2 ARID1A KCTD11 EP300 | 3.49e-04 | 1141 | 50 | 10 | GO:0045597 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 3.67e-04 | 254 | 50 | 5 | GO:0000819 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 3.88e-04 | 142 | 50 | 4 | GO:0034728 | |
| GeneOntologyBiologicalProcess | heart development | 4.35e-04 | 757 | 50 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 4.53e-04 | 266 | 50 | 5 | GO:0033044 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 4.87e-04 | 416 | 50 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 4.93e-04 | 271 | 50 | 5 | GO:0000082 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | BCL9L ATG7 MYCBP2 ATXN2 EIF4G2 SMARCA4 LAMB3 POTEJ SLC1A3 EP300 | 5.00e-04 | 1194 | 50 | 10 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 5.32e-04 | 423 | 50 | 6 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 5.73e-04 | 429 | 50 | 6 | GO:1902105 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NCOA3 ARID1B UBTFL6 ATG7 SMARCA4 SMARCC1 SMARCD2 ARID1A EP300 | 5.90e-04 | 999 | 50 | 9 | GO:0071824 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 6.03e-04 | 605 | 50 | 7 | GO:0071407 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 6.58e-04 | 614 | 50 | 7 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 7.10e-04 | 447 | 50 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 7.27e-04 | 449 | 50 | 6 | GO:0050867 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 7.65e-04 | 17 | 50 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 7.65e-04 | 17 | 50 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | response to hormone | NCOA2 NCOA3 ZNF536 ARID1B SRD5A1 SMARCA4 SMARCC1 ARID1A EP300 | 7.98e-04 | 1042 | 50 | 9 | GO:0009725 |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 8.06e-04 | 458 | 50 | 6 | GO:0050863 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 8.53e-04 | 306 | 50 | 5 | GO:0044843 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 8.60e-04 | 18 | 50 | 2 | GO:0006361 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 8.60e-04 | 18 | 50 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 8.60e-04 | 18 | 50 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 8.87e-04 | 177 | 50 | 4 | GO:0055007 | |
| GeneOntologyBiologicalProcess | C-terminal protein amino acid modification | 9.59e-04 | 19 | 50 | 2 | GO:0018410 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 1.10e-03 | 486 | 50 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ARID1B ATG7 EIF4G2 SMARCA4 SMARCC1 SMARCD2 ARID1A KCTD11 EP300 | 1.13e-03 | 1095 | 50 | 9 | GO:0060284 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.24e-03 | 333 | 50 | 5 | GO:0051054 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.30e-03 | 896 | 50 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.40e-03 | 906 | 50 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | T cell activation | 1.42e-03 | 701 | 50 | 7 | GO:0042110 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.45e-03 | 911 | 50 | 8 | GO:0048589 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 BCL9L NCOA3 MAZ SMARCA4 SMARCC1 SSBP2 BCL9 MAML3 EP300 | 1.61e-03 | 1390 | 50 | 10 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.64e-03 | 929 | 50 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.67e-03 | 356 | 50 | 5 | GO:0098813 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 1.72e-03 | 531 | 50 | 6 | GO:0042692 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.82e-03 | 537 | 50 | 6 | GO:0030098 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.95e-03 | 741 | 50 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 2.01e-03 | 221 | 50 | 4 | GO:0035051 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 2.06e-03 | 748 | 50 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 2.21e-03 | 558 | 50 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.27e-03 | 561 | 50 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.33e-03 | 564 | 50 | 6 | GO:0051052 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.37e-03 | 566 | 50 | 6 | GO:0007409 | |
| GeneOntologyCellularComponent | bBAF complex | 6.02e-09 | 10 | 50 | 4 | GO:0140092 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 8.68e-09 | 30 | 50 | 5 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 2.85e-08 | 14 | 50 | 4 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 2.85e-08 | 14 | 50 | 4 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 5.16e-08 | 16 | 50 | 4 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.31e-06 | 96 | 50 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | RSC-type complex | 5.74e-06 | 15 | 50 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | ATPase complex | 1.40e-05 | 129 | 50 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 1.02e-04 | 38 | 50 | 3 | GO:0030125 | |
| GeneOntologyCellularComponent | clathrin coat | 3.26e-04 | 56 | 50 | 3 | GO:0030118 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 4.30e-04 | 13 | 50 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | GBAF complex | 5.01e-04 | 14 | 50 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | vesicle coat | 5.54e-04 | 67 | 50 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 BCL9L NCOA3 ARID1B SMARCA4 CSTF2 SMARCC1 SMARCD2 BCL9 ARID1A | 1.36e-03 | 1377 | 50 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.56e-03 | 934 | 50 | 8 | GO:0048471 | |
| GeneOntologyCellularComponent | membrane coat | 2.09e-03 | 106 | 50 | 3 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 2.09e-03 | 106 | 50 | 3 | GO:0048475 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.04e-03 | 272 | 50 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear matrix | 4.58e-03 | 140 | 50 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 5.24e-03 | 147 | 50 | 3 | GO:0030665 | |
| HumanPheno | Pneumonia | 4.51e-06 | 311 | 18 | 8 | HP:0002090 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 7.99e-06 | 12 | 18 | 3 | HP:0010746 | |
| HumanPheno | Hypoplastic fifth fingernail | 1.32e-05 | 14 | 18 | 3 | HP:0008398 | |
| HumanPheno | Prominent eyelashes | 2.44e-05 | 17 | 18 | 3 | HP:0011231 | |
| HumanPheno | Oral aversion | 2.44e-05 | 17 | 18 | 3 | HP:0012523 | |
| HumanPheno | Hypoplastic fifth toenail | 3.47e-05 | 19 | 18 | 3 | HP:0011937 | |
| HumanPheno | Short phalanx of the 5th toe | 3.53e-05 | 3 | 18 | 2 | HP:0100368 | |
| HumanPheno | Long eyelashes | 6.34e-05 | 129 | 18 | 5 | HP:0000527 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 7.05e-05 | 4 | 18 | 2 | HP:0010343 | |
| HumanPheno | Papillary thyroid carcinoma | 7.16e-05 | 24 | 18 | 3 | HP:0002895 | |
| HumanPheno | Respiratory tract infection | ARID1B ACADVL MTHFD1 SMARCA4 LAMB3 SMARCD2 DEPDC5 CTPS1 ARID1A EP300 | 1.10e-04 | 797 | 18 | 10 | HP:0011947 |
| HumanPheno | Hepatoblastoma | 1.15e-04 | 28 | 18 | 3 | HP:0002884 | |
| HumanPheno | Wide nasal base | 1.15e-04 | 28 | 18 | 3 | HP:0012810 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 1.17e-04 | 5 | 18 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 1.17e-04 | 5 | 18 | 2 | HP:0010342 | |
| HumanPheno | Abnormal nasal base norphology | 1.42e-04 | 30 | 18 | 3 | HP:0012808 | |
| HumanPheno | Thick eyebrow | 1.47e-04 | 154 | 18 | 5 | HP:0000574 | |
| HumanPheno | Prominent interphalangeal joints | 1.75e-04 | 6 | 18 | 2 | HP:0006237 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 2.46e-04 | 36 | 18 | 3 | HP:0010173 | |
| HumanPheno | Sandal gap | 2.96e-04 | 96 | 18 | 4 | HP:0001852 | |
| HumanPheno | Thick nasal alae | 3.13e-04 | 39 | 18 | 3 | HP:0009928 | |
| HumanPheno | Broad philtrum | 4.79e-04 | 45 | 18 | 3 | HP:0000289 | |
| Domain | Nuc_rcpt_coact | 3.59e-07 | 6 | 50 | 3 | IPR009110 | |
| Domain | BCL9_beta-catenin-bd_dom | 7.02e-06 | 2 | 50 | 2 | IPR024670 | |
| Domain | BAF250_C | 7.02e-06 | 2 | 50 | 2 | IPR033388 | |
| Domain | BCL9 | 7.02e-06 | 2 | 50 | 2 | PF11502 | |
| Domain | DUF4927 | 7.02e-06 | 2 | 50 | 2 | PF16279 | |
| Domain | DUF4927 | 7.02e-06 | 2 | 50 | 2 | IPR032565 | |
| Domain | BAF250_C | 7.02e-06 | 2 | 50 | 2 | PF12031 | |
| Domain | BAF250/Osa | 7.02e-06 | 2 | 50 | 2 | IPR021906 | |
| Domain | Bcl-9 | 7.02e-06 | 2 | 50 | 2 | IPR015668 | |
| Domain | DUF1518 | 2.10e-05 | 3 | 50 | 2 | PF07469 | |
| Domain | DUF1518 | 2.10e-05 | 3 | 50 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 2.10e-05 | 3 | 50 | 2 | IPR014920 | |
| Domain | SRC-1 | 2.10e-05 | 3 | 50 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 2.10e-05 | 3 | 50 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 2.10e-05 | 3 | 50 | 2 | IPR017426 | |
| Domain | DUF1518 | 2.10e-05 | 3 | 50 | 2 | SM01151 | |
| Domain | SRC-1 | 2.10e-05 | 3 | 50 | 2 | PF08832 | |
| Domain | - | 2.10e-05 | 3 | 50 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 2.10e-05 | 3 | 50 | 2 | PF08815 | |
| Domain | ENTH | 1.05e-04 | 6 | 50 | 2 | PF01417 | |
| Domain | ENTH | 2.50e-04 | 9 | 50 | 2 | PS50942 | |
| Domain | ENTH | 2.50e-04 | 9 | 50 | 2 | SM00273 | |
| Domain | ENTH | 3.12e-04 | 10 | 50 | 2 | IPR013809 | |
| Domain | - | 7.21e-04 | 15 | 50 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 7.21e-04 | 15 | 50 | 2 | SM00501 | |
| Domain | ARID_dom | 7.21e-04 | 15 | 50 | 2 | IPR001606 | |
| Domain | ARID | 7.21e-04 | 15 | 50 | 2 | PS51011 | |
| Domain | ARID | 7.21e-04 | 15 | 50 | 2 | PF01388 | |
| Domain | Laminin_N | 8.23e-04 | 16 | 50 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 8.23e-04 | 16 | 50 | 2 | PS51117 | |
| Domain | Laminin_N | 8.23e-04 | 16 | 50 | 2 | PF00055 | |
| Domain | LamNT | 8.23e-04 | 16 | 50 | 2 | SM00136 | |
| Domain | PAS | 2.03e-03 | 25 | 50 | 2 | PF00989 | |
| Domain | PAS_fold | 2.03e-03 | 25 | 50 | 2 | IPR013767 | |
| Domain | Bromodomain_CS | 2.19e-03 | 26 | 50 | 2 | IPR018359 | |
| Domain | - | 2.19e-03 | 26 | 50 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 2.72e-03 | 29 | 50 | 2 | IPR008942 | |
| Domain | EGF_LAM_2 | 2.91e-03 | 30 | 50 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.91e-03 | 30 | 50 | 2 | PS01248 | |
| Domain | PAS | 3.31e-03 | 32 | 50 | 2 | SM00091 | |
| Domain | PAS | 3.73e-03 | 34 | 50 | 2 | IPR000014 | |
| Domain | PAS | 3.73e-03 | 34 | 50 | 2 | PS50112 | |
| Domain | Laminin_EGF | 3.95e-03 | 35 | 50 | 2 | PF00053 | |
| Domain | EGF_Lam | 3.95e-03 | 35 | 50 | 2 | SM00180 | |
| Domain | BROMODOMAIN_1 | 4.41e-03 | 37 | 50 | 2 | PS00633 | |
| Domain | Bromodomain | 4.64e-03 | 38 | 50 | 2 | PF00439 | |
| Domain | Laminin_EGF | 4.64e-03 | 38 | 50 | 2 | IPR002049 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.55e-10 | 37 | 38 | 6 | M27797 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.76e-09 | 22 | 38 | 5 | MM1370 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.23e-08 | 29 | 38 | 5 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.75e-08 | 31 | 38 | 5 | M39522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.85e-08 | 34 | 38 | 5 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.31e-08 | 35 | 38 | 5 | M47969 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 8.57e-08 | 42 | 38 | 5 | M48237 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.79e-07 | 237 | 38 | 8 | M27786 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.85e-07 | 95 | 38 | 6 | M48268 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.59e-07 | 24 | 38 | 4 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.43e-07 | 26 | 38 | 4 | MM14793 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.61e-06 | 137 | 38 | 6 | M48232 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.98e-06 | 78 | 38 | 5 | M27234 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 2.14e-06 | 10 | 38 | 3 | MM1532 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.07e-06 | 153 | 38 | 6 | MM15522 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 3.83e-06 | 40 | 38 | 4 | MM14936 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 3.91e-06 | 12 | 38 | 3 | M22006 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 5.83e-06 | 97 | 38 | 5 | M48262 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.97e-06 | 272 | 38 | 7 | M29619 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 8.04e-06 | 15 | 38 | 3 | M119 | |
| Pathway | WP_THERMOGENESIS | 9.87e-06 | 108 | 38 | 5 | M39746 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 1.08e-05 | 110 | 38 | 5 | M48043 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.71e-05 | 142 | 38 | 5 | M48257 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 5.49e-05 | 254 | 38 | 6 | M27131 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 6.13e-05 | 80 | 38 | 4 | M223 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.18e-05 | 158 | 38 | 5 | MM14791 | |
| Pathway | PID_REG_GR_PATHWAY | 6.75e-05 | 82 | 38 | 4 | M115 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 6.98e-05 | 30 | 38 | 3 | M207 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.00e-04 | 175 | 38 | 5 | MM14941 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.01e-04 | 91 | 38 | 4 | M27101 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.31e-04 | 330 | 38 | 6 | M7847 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.14e-04 | 10 | 38 | 2 | MM15535 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.80e-04 | 233 | 38 | 5 | M27099 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.83e-04 | 11 | 38 | 2 | M47503 | |
| Pathway | PID_AR_TF_PATHWAY | 3.86e-04 | 53 | 38 | 3 | M151 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.27e-04 | 239 | 38 | 5 | MM14756 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.59e-04 | 12 | 38 | 2 | M27159 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.31e-04 | 14 | 38 | 2 | M27808 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 6.69e-04 | 149 | 38 | 4 | M27888 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 6.72e-04 | 64 | 38 | 3 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.03e-04 | 65 | 38 | 3 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 8.29e-04 | 16 | 38 | 2 | M27121 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 8.37e-04 | 69 | 38 | 3 | M46439 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA2 NCOA3 ARID1B SMARCA4 SMARCC1 TNRC6B SMARCD2 ARID1A PSMD14 MAML3 EP300 | 1.03e-03 | 1432 | 38 | 11 | M509 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.05e-03 | 18 | 38 | 2 | MM14775 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.05e-03 | 18 | 38 | 2 | M26942 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.11e-03 | 76 | 38 | 3 | MM15520 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SMARCA4 CSTF2 SMARCC1 TNRC6B SMARCD2 ARID1A PSMD14 MAML3 EP300 | 1.28e-03 | 1022 | 38 | 9 | MM15436 |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.30e-03 | 20 | 38 | 2 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.38e-03 | 82 | 38 | 3 | M594 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.44e-03 | 21 | 38 | 2 | M39593 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.48e-03 | 84 | 38 | 3 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.86e-03 | 91 | 38 | 3 | M39700 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.98e-03 | 93 | 38 | 3 | M27572 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.04e-03 | 25 | 38 | 2 | M27880 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.17e-03 | 96 | 38 | 3 | M27784 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.56e-03 | 28 | 38 | 2 | M48253 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 2.74e-03 | 29 | 38 | 2 | MM15291 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.81e-03 | 220 | 38 | 4 | M27794 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ARID1B SMARCA4 CSTF2 SMARCC1 TNRC6B SMARCD2 ARID1A PSMD14 MAML3 EP300 | 2.97e-03 | 1387 | 38 | 10 | M734 |
| Pathway | REACTOME_ADIPOGENESIS | 3.20e-03 | 110 | 38 | 3 | M48259 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 3.33e-03 | 32 | 38 | 2 | M39567 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.54e-03 | 33 | 38 | 2 | M604 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.90e-03 | 118 | 38 | 3 | M27316 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 3.98e-03 | 768 | 38 | 7 | MM14851 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.99e-03 | 119 | 38 | 3 | M607 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 4.19e-03 | 246 | 38 | 4 | M10189 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 4.44e-03 | 37 | 38 | 2 | M27580 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 4.44e-03 | 37 | 38 | 2 | M29790 | |
| Pubmed | 4.50e-15 | 83 | 51 | 9 | 28794006 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 BCL9L NCOA3 ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A EP300 | 1.03e-13 | 351 | 51 | 12 | 38297188 |
| Pubmed | NCOA2 BCL9L NCOA3 ZNF536 ARID1B ATXN2 MAZ SMARCA4 CSTF2 SMARCC1 TNRC6B SMARCD2 SSBP2 R3HDM1 BCL9 ARID1A PSMD14 EP300 | 7.70e-13 | 1429 | 51 | 18 | 35140242 | |
| Pubmed | 1.83e-12 | 55 | 51 | 7 | 35945219 | ||
| Pubmed | NCOA2 NCOA3 ARID1B MYCBP2 ATXN2 MTHFD1 EIF4G2 SMARCA4 SMARCC1 SMARCD2 CLINT1 CTPS1 BCL9 ARID1A PSMD14 EP300 | 2.38e-12 | 1103 | 51 | 16 | 34189442 | |
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 4.10e-12 | 4 | 51 | 4 | 15170388 | |
| Pubmed | NCOA2 BCL9L NCOA3 ARID1B SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A | 6.04e-12 | 268 | 51 | 10 | 33640491 | |
| Pubmed | 1.65e-11 | 15 | 51 | 5 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 1.65e-11 | 15 | 51 | 5 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 1.65e-11 | 15 | 51 | 5 | 17920018 | |
| Pubmed | NCOA2 SYNRG ARID1B MYCBP2 SMARCA4 CSTF2 SMARCC1 TNRC6B CLINT1 CTPS1 ARID1A EP300 | 1.93e-11 | 549 | 51 | 12 | 38280479 | |
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 14966121 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.71e-11 | 40 | 51 | 6 | 34585037 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 3.38e-11 | 17 | 51 | 5 | 12368262 | |
| Pubmed | 3.38e-11 | 17 | 51 | 5 | 11078522 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 4.68e-11 | 18 | 51 | 5 | 23698369 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 BCL9L NCOA3 ARID1B ATXN2 SMARCC1 TNRC6B BCL9 ARID1A MAML3 EP300 | 5.31e-11 | 457 | 51 | 11 | 32344865 |
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 16230384 | ||
| Pubmed | 6.34e-11 | 19 | 51 | 5 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 6.34e-11 | 19 | 51 | 5 | 12110891 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 23540691 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.43e-10 | 7 | 51 | 4 | 9590696 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.83e-10 | 23 | 51 | 5 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 1.83e-10 | 23 | 51 | 5 | 8804307 | |
| Pubmed | 2.31e-10 | 24 | 51 | 5 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 2.31e-10 | 24 | 51 | 5 | 10078207 | |
| Pubmed | 2.31e-10 | 24 | 51 | 5 | 12215535 | ||
| Pubmed | 3.56e-10 | 26 | 51 | 5 | 10778858 | ||
| Pubmed | 4.37e-10 | 27 | 51 | 5 | 29374058 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 5.14e-10 | 9 | 51 | 4 | 20086098 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 37805104 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 5.31e-10 | 28 | 51 | 5 | 12192000 | |
| Pubmed | 5.67e-10 | 65 | 51 | 6 | 26655900 | ||
| Pubmed | 7.68e-10 | 30 | 51 | 5 | 31043422 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 8.55e-10 | 10 | 51 | 4 | 16751102 | |
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 12665591 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 18003620 | ||
| Pubmed | 1.74e-09 | 78 | 51 | 6 | 28611094 | ||
| Pubmed | 1.74e-09 | 35 | 51 | 5 | 32504627 | ||
| Pubmed | NCOA2 NCOA3 ZNF536 ARID1B SMARCC1 POTEJ BCL9 ARID1A SLC1A3 MAML3 EP300 | 1.78e-09 | 638 | 51 | 11 | 31182584 | |
| Pubmed | 2.01e-09 | 12 | 51 | 4 | 11734557 | ||
| Pubmed | 2.33e-09 | 37 | 51 | 5 | 24335282 | ||
| Pubmed | Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. | 2.90e-09 | 13 | 51 | 4 | 11726552 | |
| Pubmed | 2.90e-09 | 13 | 51 | 4 | 17340523 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 2.97e-09 | 3 | 51 | 3 | 22426308 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 4.06e-09 | 14 | 51 | 4 | 8895581 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 5.53e-09 | 15 | 51 | 4 | 17255939 | |
| Pubmed | 5.53e-09 | 15 | 51 | 4 | 23785148 | ||
| Pubmed | 5.53e-09 | 15 | 51 | 4 | 15985610 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 6.12e-09 | 398 | 51 | 9 | 35016035 | |
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 7.37e-09 | 16 | 51 | 4 | 35390516 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 8.19e-09 | 283 | 51 | 8 | 28533407 | |
| Pubmed | 9.62e-09 | 17 | 51 | 4 | 19183483 | ||
| Pubmed | 1.08e-08 | 425 | 51 | 9 | 24999758 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 28863077 | ||
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 1.19e-08 | 4 | 51 | 3 | 11988099 | |
| Pubmed | 1.24e-08 | 18 | 51 | 4 | 14559996 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 1.24e-08 | 18 | 51 | 4 | 28068325 | |
| Pubmed | 1.56e-08 | 19 | 51 | 4 | 25066234 | ||
| Pubmed | 1.56e-08 | 19 | 51 | 4 | 18809673 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12714702 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 18086889 | ||
| Pubmed | p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. | 2.96e-08 | 5 | 51 | 3 | 9584200 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12200431 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 2.96e-08 | 5 | 51 | 3 | 9812974 | |
| Pubmed | 3.10e-08 | 61 | 51 | 5 | 20305087 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.37e-08 | 220 | 51 | 7 | 35785414 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 16940996 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 5.92e-08 | 6 | 51 | 3 | 25081545 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 10943845 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 23933087 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 16923966 | ||
| Pubmed | 8.18e-08 | 28 | 51 | 4 | 30037996 | ||
| Pubmed | 9.48e-08 | 29 | 51 | 4 | 36800290 | ||
| Pubmed | 9.48e-08 | 29 | 51 | 4 | 19279220 | ||
| Pubmed | 9.66e-08 | 152 | 51 | 6 | 38360978 | ||
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 28369036 | ||
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 1.04e-07 | 7 | 51 | 3 | 21118156 | |
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 12709428 | ||
| Pubmed | 1.17e-07 | 157 | 51 | 6 | 30186101 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 12082103 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 32640256 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 36335117 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 26986003 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 14747462 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 10490106 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 23556151 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 11087842 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 9845365 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 14729568 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 3.54e-07 | 10 | 51 | 3 | 23129809 | |
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 34716243 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 35210568 | ||
| Pubmed | Functional selectivity of recombinant mammalian SWI/SNF subunits. | 4.86e-07 | 11 | 51 | 3 | 11018012 | |
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 12917342 | ||
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 33723076 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.73e-07 | 724 | 51 | 9 | 36232890 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 1.07e-06 | 14 | 51 | 3 | 11500849 | |
| Pubmed | ZNF536 ARID1B MYCBP2 SMARCA4 CSTF2 TNRC6B R3HDM1 CTPS1 PSMD14 | 1.08e-06 | 733 | 51 | 9 | 34672954 | |
| Pubmed | 1.14e-06 | 53 | 51 | 4 | 35216969 | ||
| Interaction | TBXT interactions | NCOA2 NCOA3 ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A EP300 | 5.55e-15 | 116 | 51 | 11 | int:TBXT |
| Interaction | TBR1 interactions | NCOA2 BCL9L NCOA3 ZNF536 ARID1B MYCBP2 SMARCD2 BCL9 ARID1A EP300 | 2.16e-13 | 113 | 51 | 10 | int:TBR1 |
| Interaction | GCM1 interactions | 6.23e-12 | 68 | 51 | 8 | int:GCM1 | |
| Interaction | EGR2 interactions | NCOA2 BCL9L NCOA3 ZNF536 ARID1B SMARCC1 SSBP2 BCL9 ARID1A EP300 | 1.41e-11 | 171 | 51 | 10 | int:EGR2 |
| Interaction | TLX1 interactions | NCOA2 NCOA3 ZNF536 ARID1B SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A EP300 | 1.77e-11 | 175 | 51 | 10 | int:TLX1 |
| Interaction | SOX7 interactions | 2.93e-11 | 82 | 51 | 8 | int:SOX7 | |
| Interaction | PAX9 interactions | 3.54e-11 | 130 | 51 | 9 | int:PAX9 | |
| Interaction | GATA2 interactions | NCOA3 ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A EP300 | 6.31e-11 | 199 | 51 | 10 | int:GATA2 |
| Interaction | SOX9 interactions | 1.15e-10 | 97 | 51 | 8 | int:SOX9 | |
| Interaction | SP7 interactions | NCOA2 BCL9L NCOA3 ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 2.14e-10 | 304 | 51 | 11 | int:SP7 |
| Interaction | ETV4 interactions | 4.15e-10 | 69 | 51 | 7 | int:ETV4 | |
| Interaction | WWTR1 interactions | NCOA2 SYNRG ARID1B MYCBP2 SMARCA4 CSTF2 SMARCC1 TNRC6B CLINT1 CTPS1 ARID1A EP300 | 4.62e-10 | 422 | 51 | 12 | int:WWTR1 |
| Interaction | CRX interactions | NCOA2 BCL9L NCOA3 ZNF536 ARID1B SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 6.88e-10 | 254 | 51 | 10 | int:CRX |
| Interaction | ALG13 interactions | 7.55e-10 | 183 | 51 | 9 | int:ALG13 | |
| Interaction | LHX2 interactions | BCL9L ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A | 7.55e-10 | 183 | 51 | 9 | int:LHX2 |
| Interaction | GATA3 interactions | TINAGL1 NCOA3 ZNF536 ARID1B SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 9.14e-10 | 187 | 51 | 9 | int:GATA3 |
| Interaction | MYOD1 interactions | NCOA2 NCOA3 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 1.26e-09 | 194 | 51 | 9 | int:MYOD1 |
| Interaction | FOXI1 interactions | 3.22e-09 | 92 | 51 | 7 | int:FOXI1 | |
| Interaction | DPF3 interactions | 4.04e-09 | 95 | 51 | 7 | int:DPF3 | |
| Interaction | ERG interactions | NCOA2 NCOA3 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 4.30e-09 | 223 | 51 | 9 | int:ERG |
| Interaction | FOS interactions | NCOA2 NCOA3 ARID1B MAZ SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 4.99e-09 | 312 | 51 | 10 | int:FOS |
| Interaction | SS18L1 interactions | 5.03e-09 | 98 | 51 | 7 | int:SS18L1 | |
| Interaction | TPRX2 interactions | 5.71e-09 | 56 | 51 | 6 | int:TPRX2 | |
| Interaction | NUP35 interactions | NCOA2 BCL9L NCOA3 ARID1B ATXN2 SMARCC1 TNRC6B BCL9 ARID1A MAML3 EP300 | 7.02e-09 | 424 | 51 | 11 | int:NUP35 |
| Interaction | LHX4 interactions | 8.43e-09 | 166 | 51 | 8 | int:LHX4 | |
| Interaction | PAX8 interactions | 1.20e-08 | 111 | 51 | 7 | int:PAX8 | |
| Interaction | ETS1 interactions | 2.20e-08 | 121 | 51 | 7 | int:ETS1 | |
| Interaction | HNF1B interactions | 2.42e-08 | 190 | 51 | 8 | int:HNF1B | |
| Interaction | KLF5 interactions | 2.97e-08 | 195 | 51 | 8 | int:KLF5 | |
| Interaction | CEBPA interactions | NCOA2 NCOA3 ARID1B MYCBP2 ATXN2 MTHFD1 EIF4G2 SMARCA4 SMARCC1 SMARCD2 CLINT1 CTPS1 BCL9 ARID1A PSMD14 EP300 | 3.74e-08 | 1245 | 51 | 16 | int:CEBPA |
| Interaction | GSC interactions | 8.37e-08 | 87 | 51 | 6 | int:GSC | |
| Interaction | SS18 interactions | 8.97e-08 | 88 | 51 | 6 | int:SS18 | |
| Interaction | CARM1 interactions | NCOA2 NCOA3 MYCBP2 SMARCA4 SMARCC1 TNRC6B DEPDC5 ARID1A EP300 | 1.11e-07 | 325 | 51 | 9 | int:CARM1 |
| Interaction | SOX10 interactions | 1.17e-07 | 92 | 51 | 6 | int:SOX10 | |
| Interaction | SOX17 interactions | 1.42e-07 | 95 | 51 | 6 | int:SOX17 | |
| Interaction | KLF4 interactions | 1.50e-07 | 160 | 51 | 7 | int:KLF4 | |
| Interaction | TEX13B interactions | 1.71e-07 | 20 | 51 | 4 | int:TEX13B | |
| Interaction | PRMT5 interactions | TINAGL1 ARID1B MTHFD1 SMARCA4 SMARCC1 SMARCD2 CTPS1 ARID1A PSMD14 EP300 | 2.39e-07 | 471 | 51 | 10 | int:PRMT5 |
| Interaction | EWSR1 interactions | BCL9L NCOA3 MYCBP2 MAZ SMARCA4 CSTF2 SMARCC1 SSBP2 CLINT1 R3HDM1 BCL9 ARID1A EP300 | 2.73e-07 | 906 | 51 | 13 | int:EWSR1 |
| Interaction | TEAD1 interactions | 2.88e-07 | 176 | 51 | 7 | int:TEAD1 | |
| Interaction | PAX6 interactions | NCOA3 ZNF536 ARID1B SMARCA4 SMARCC1 SMARCD2 BCL9 ARID1A EP300 | 3.02e-07 | 366 | 51 | 9 | int:PAX6 |
| Interaction | TLE3 interactions | 3.79e-07 | 376 | 51 | 9 | int:TLE3 | |
| Interaction | HNF4A interactions | 4.16e-07 | 275 | 51 | 8 | int:HNF4A | |
| Interaction | ARHGAP18 interactions | 4.42e-07 | 115 | 51 | 6 | int:ARHGAP18 | |
| Interaction | NFIA interactions | 4.50e-07 | 188 | 51 | 7 | int:NFIA | |
| Interaction | FLI1 interactions | 4.93e-07 | 62 | 51 | 5 | int:FLI1 | |
| Interaction | DDIT3 interactions | 5.69e-07 | 120 | 51 | 6 | int:DDIT3 | |
| Interaction | SMARCE1 interactions | 5.75e-07 | 287 | 51 | 8 | int:SMARCE1 | |
| Interaction | NR3C1 interactions | NCOA2 NCOA3 ZNF536 ARID1B ACADVL SMARCA4 SMARCC1 POTEJ BCL9 ARID1A SLC1A3 MAML3 EP300 | 6.23e-07 | 974 | 51 | 13 | int:NR3C1 |
| Interaction | BCL7A interactions | 6.58e-07 | 123 | 51 | 6 | int:BCL7A | |
| Interaction | PAX7 interactions | 6.90e-07 | 124 | 51 | 6 | int:PAX7 | |
| Interaction | BICRA interactions | 7.28e-07 | 67 | 51 | 5 | int:BICRA | |
| Interaction | FEV interactions | 7.55e-07 | 203 | 51 | 7 | int:FEV | |
| Interaction | AR interactions | NCOA2 BCL9L NCOA3 ARID1B MYCBP2 SMARCA4 SMARCC1 SMARCD2 SSBP2 BCL9 ARID1A PSMD14 EP300 | 7.66e-07 | 992 | 51 | 13 | int:AR |
| Interaction | NR4A1 interactions | 1.01e-06 | 212 | 51 | 7 | int:NR4A1 | |
| Interaction | SMG7 interactions | 1.27e-06 | 319 | 51 | 8 | int:SMG7 | |
| Interaction | SS18L2 interactions | 1.37e-06 | 76 | 51 | 5 | int:SS18L2 | |
| Interaction | SOX15 interactions | 1.47e-06 | 141 | 51 | 6 | int:SOX15 | |
| Interaction | NCOA1 interactions | 1.80e-06 | 146 | 51 | 6 | int:NCOA1 | |
| Interaction | STK11IP interactions | 2.12e-06 | 83 | 51 | 5 | int:STK11IP | |
| Interaction | IRF1 interactions | 2.12e-06 | 83 | 51 | 5 | int:IRF1 | |
| Interaction | KLF1 interactions | 2.26e-06 | 37 | 51 | 4 | int:KLF1 | |
| Interaction | PML interactions | NCOA2 SYNRG MTHFD1 VWA5A EIF4G2 SMARCA4 SFXN2 TNRC6B CLINT1 CTPS1 PSMD14 EP300 | 2.70e-06 | 933 | 51 | 12 | int:PML |
| Interaction | SMARCC2 interactions | 2.70e-06 | 353 | 51 | 8 | int:SMARCC2 | |
| Interaction | PTPN23 interactions | 3.28e-06 | 162 | 51 | 6 | int:PTPN23 | |
| Interaction | DPF1 interactions | 4.14e-06 | 95 | 51 | 5 | int:DPF1 | |
| Interaction | BCL7B interactions | 4.14e-06 | 95 | 51 | 5 | int:BCL7B | |
| Interaction | GATA1 interactions | 4.49e-06 | 171 | 51 | 6 | int:GATA1 | |
| Interaction | SMARCC1 interactions | 5.03e-06 | 384 | 51 | 8 | int:SMARCC1 | |
| Interaction | ARID1B interactions | 5.47e-06 | 177 | 51 | 6 | int:ARID1B | |
| Interaction | ARID1A interactions | 5.79e-06 | 276 | 51 | 7 | int:ARID1A | |
| Interaction | LHX1 interactions | 6.16e-06 | 103 | 51 | 5 | int:LHX1 | |
| Interaction | SMARCD3 interactions | 7.43e-06 | 107 | 51 | 5 | int:SMARCD3 | |
| Interaction | ACTL6A interactions | 7.83e-06 | 289 | 51 | 7 | int:ACTL6A | |
| Interaction | SMAP2 interactions | 7.97e-06 | 189 | 51 | 6 | int:SMAP2 | |
| Interaction | TLX3 interactions | 8.18e-06 | 291 | 51 | 7 | int:TLX3 | |
| Interaction | BRCA1 interactions | NCOA2 NCOA3 MTHFD1 SMARCA4 CSTF2 SMARCC1 TNRC6B SMARCD2 CTPS1 ARID1A PSMD14 HIBADH EP300 | 9.73e-06 | 1249 | 51 | 13 | int:BRCA1 |
| Interaction | BCL7C interactions | 1.06e-05 | 115 | 51 | 5 | int:BCL7C | |
| Interaction | BRD9 interactions | 1.15e-05 | 117 | 51 | 5 | int:BRD9 | |
| Interaction | PPARG interactions | 1.16e-05 | 307 | 51 | 7 | int:PPARG | |
| Interaction | LHX6 interactions | 1.40e-05 | 58 | 51 | 4 | int:LHX6 | |
| Interaction | MLLT1 interactions | 1.46e-05 | 123 | 51 | 5 | int:MLLT1 | |
| Interaction | SSBP4 interactions | 1.49e-05 | 59 | 51 | 4 | int:SSBP4 | |
| Interaction | MRTFA interactions | 1.60e-05 | 60 | 51 | 4 | int:MRTFA | |
| Interaction | RUNX1 interactions | 1.64e-05 | 324 | 51 | 7 | int:RUNX1 | |
| Interaction | SMARCA2 interactions | 2.50e-05 | 346 | 51 | 7 | int:SMARCA2 | |
| Interaction | PHF10 interactions | 2.64e-05 | 139 | 51 | 5 | int:PHF10 | |
| Interaction | NFIB interactions | 2.93e-05 | 142 | 51 | 5 | int:NFIB | |
| Interaction | EYA4 interactions | 3.30e-05 | 243 | 51 | 6 | int:EYA4 | |
| Interaction | ASF1A interactions | 3.79e-05 | 249 | 51 | 6 | int:ASF1A | |
| Interaction | SOX2 interactions | NCOA2 BCL9L NCOA3 ZNF536 ARID1B KSR2 SMARCA4 SMARCC1 SMARCD2 CLINT1 BCL9 ARID1A EP300 | 3.85e-05 | 1422 | 51 | 13 | int:SOX2 |
| Interaction | ARID2 interactions | 4.19e-05 | 153 | 51 | 5 | int:ARID2 | |
| Interaction | ACTG1 interactions | 4.47e-05 | 520 | 51 | 8 | int:ACTG1 | |
| Interaction | PYGO1 interactions | 4.78e-05 | 28 | 51 | 3 | int:PYGO1 | |
| Interaction | SMAD2 interactions | 4.94e-05 | 385 | 51 | 7 | int:SMAD2 | |
| Interaction | ESRRB interactions | 5.03e-05 | 262 | 51 | 6 | int:ESRRB | |
| Interaction | LMO4 interactions | 5.03e-05 | 159 | 51 | 5 | int:LMO4 | |
| Interaction | HDAC2 interactions | ACADVL MYCBP2 EIF4G2 SMARCA4 SMARCC1 SMARCD2 CLINT1 CTPS1 ARID1A EP300 | 5.19e-05 | 865 | 51 | 10 | int:HDAC2 |
| Interaction | STAT2 interactions | 5.24e-05 | 81 | 51 | 4 | int:STAT2 | |
| Interaction | ETV1 interactions | 5.33e-05 | 29 | 51 | 3 | int:ETV1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.53e-08 | 25 | 25 | 4 | 775 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.57e-06 | 17 | 25 | 3 | 486 | |
| GeneFamily | Laminin subunits | 1.20e-04 | 12 | 25 | 2 | 626 | |
| GeneFamily | AT-rich interaction domain containing | 1.91e-04 | 15 | 25 | 2 | 418 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.00e-02 | 110 | 25 | 2 | 420 | |
| Coexpression | GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.57e-05 | 165 | 50 | 5 | M9094 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 2.71e-05 | 843 | 50 | 9 | M2356 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 3.94e-05 | 200 | 50 | 5 | M5991 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 3.94e-05 | 200 | 50 | 5 | M5926 | |
| Coexpression | GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN | 3.94e-05 | 200 | 50 | 5 | M6791 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 6.25e-05 | 112 | 50 | 4 | M4939 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 6.93e-05 | 115 | 50 | 4 | MM599 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 9.23e-05 | 988 | 50 | 9 | M6616 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.82e-06 | 249 | 50 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | TINAGL1 NCOA3 ATXN2 SMARCA4 SFXN2 SMARCC1 DEPDC5 SSBP2 R3HDM1 ARID1A KCTD11 | 2.12e-06 | 806 | 50 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.36e-06 | 259 | 50 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.05e-06 | 281 | 50 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.34e-06 | 284 | 50 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 3.90e-05 | 162 | 50 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.16e-05 | 403 | 50 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.58e-05 | 277 | 50 | 6 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.86e-05 | 413 | 50 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NCOA2 ZNF536 KSR2 EIF4G2 SMARCC1 LAMB3 GOLM1 R3HDM1 BCL9 ARID1A CMAHP SLC1A3 | 8.23e-05 | 1414 | 50 | 12 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NCOA3 ATXN2 SMARCA4 SFXN2 SMARCC1 DEPDC5 SSBP2 R3HDM1 ARID1A | 9.50e-05 | 804 | 50 | 9 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 SMARCA4 SFXN2 SMARCC1 DEPDC5 SSBP2 R3HDM1 ARID1A SLC1A3 | 1.05e-04 | 815 | 50 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.84e-04 | 225 | 50 | 5 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.03e-04 | 230 | 50 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 4.18e-04 | 416 | 50 | 6 | GSM791146_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 4.24e-04 | 417 | 50 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 4.28e-04 | 150 | 50 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.62e-04 | 275 | 50 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 4.76e-04 | 790 | 50 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.05e-04 | 797 | 50 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.22e-04 | 801 | 50 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 7.34e-04 | 1060 | 50 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.10e-08 | 186 | 51 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.10e-08 | 186 | 51 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.09e-07 | 131 | 51 | 5 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 195 | 51 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 199 | 51 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.63e-05 | 163 | 51 | 4 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.90e-05 | 166 | 51 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 190 | 51 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | 041124dd5c24c1eb188d2560ba606422c0b215c5 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.01e-05 | 193 | 51 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.01e-05 | 193 | 51 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 194 | 51 | 4 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.15e-05 | 194 | 51 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | 2416efe0b10ef28d0107808d1347bc34f87f92b7 | |
| ToppCell | droplet-Thymus-nan-21m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 196 | 51 | 4 | 313d66313d7c93d9ae4c8b790262ba7a85b34fe4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.57e-08 | 5 | 50 | 3 | C3281201 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 3.82e-07 | 9 | 50 | 3 | DOID:1925 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.62e-07 | 195 | 50 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.29e-06 | 13 | 50 | 3 | C0265338 | |
| Disease | prostate cancer (is_marker_for) | 6.77e-06 | 156 | 50 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.66e-05 | 41 | 50 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.66e-05 | 41 | 50 | 3 | C0858252 | |
| Disease | cancer (implicated_via_orthology) | 9.03e-05 | 268 | 50 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.18e-05 | 139 | 50 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.01e-04 | 9 | 50 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | neuroblastoma (is_implicated_in) | 1.26e-04 | 10 | 50 | 2 | DOID:769 (is_implicated_in) | |
| Disease | breast carcinoma (is_marker_for) | 1.94e-04 | 66 | 50 | 3 | DOID:3459 (is_marker_for) | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 2.17e-04 | 13 | 50 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | response to atorvastatin, myopathy | 2.17e-04 | 13 | 50 | 2 | EFO_0004145, EFO_0010124 | |
| Disease | Sarcoma, Spindle Cell | 2.53e-04 | 14 | 50 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 2.53e-04 | 14 | 50 | 2 | C0205944 | |
| Disease | testosterone measurement | 2.58e-04 | 1275 | 50 | 9 | EFO_0004908 | |
| Disease | Burkitt Leukemia | 2.91e-04 | 15 | 50 | 2 | C4721444 | |
| Disease | African Burkitt's lymphoma | 2.91e-04 | 15 | 50 | 2 | C0343640 | |
| Disease | T-Cell Lymphoma | 3.33e-04 | 16 | 50 | 2 | C0079772 | |
| Disease | diet measurement | 3.54e-04 | 1049 | 50 | 8 | EFO_0008111 | |
| Disease | cortical surface area measurement | 3.82e-04 | 1345 | 50 | 9 | EFO_0010736 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.13e-04 | 206 | 50 | 4 | C0152013 | |
| Disease | age at onset, smoking initiation | 4.72e-04 | 19 | 50 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | Sarcoma | 5.79e-04 | 21 | 50 | 2 | C1261473 | |
| Disease | hypertension (biomarker_via_orthology) | 5.95e-04 | 227 | 50 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 6.59e-04 | 100 | 50 | 3 | C0010606 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 7.19e-04 | 103 | 50 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 7.58e-04 | 24 | 50 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | breast cancer (implicated_via_orthology) | 8.23e-04 | 25 | 50 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | unipolar depression, depressive symptom measurement | 8.91e-04 | 26 | 50 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Sezary Syndrome | 9.61e-04 | 27 | 50 | 2 | C0036920 | |
| Disease | Carcinoma, Granular Cell | 1.01e-03 | 116 | 50 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.01e-03 | 116 | 50 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.01e-03 | 116 | 50 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.01e-03 | 116 | 50 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.01e-03 | 116 | 50 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.01e-03 | 116 | 50 | 3 | C0001418 | |
| Disease | cardiovascular disease | 1.04e-03 | 457 | 50 | 5 | EFO_0000319 | |
| Disease | diastolic blood pressure, unipolar depression | 1.19e-03 | 30 | 50 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | creatinine measurement | 1.37e-03 | 995 | 50 | 7 | EFO_0004518 | |
| Disease | systolic blood pressure, body mass index | 1.52e-03 | 34 | 50 | 2 | EFO_0004340, EFO_0006335 | |
| Disease | ovarian neoplasm | 1.54e-03 | 134 | 50 | 3 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.64e-03 | 137 | 50 | 3 | C1140680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGMPGKLIKINIMNM | 81 | Q8NDL9 | |
| PGQSPQGMRPMSNMS | 496 | Q09472 | |
| AAGMVPVSMNPGPNM | 661 | Q09472 | |
| LSSPRQQGGGMMMGP | 451 | Q8NFD5 | |
| GMHVNGAPPLMQASM | 236 | P33240 | |
| PGGGMVMMQLSVPNN | 826 | Q15032 | |
| PMTMQGRAQSAMGGL | 431 | O14497 | |
| MRKGTAMKGLQMTGP | 1006 | O75140 | |
| TNALIGGPMPMSMPN | 541 | Q14677 | |
| SRLMAQNAGMMGIGP | 826 | Q96JK9 | |
| MGRQMMPSLPGQQGT | 1026 | Q96JK9 | |
| PLGPAMMNMVGSVGI | 611 | O95208 | |
| MMLMTTQPPGGPQAA | 1266 | Q99700 | |
| MGTGMKPNLSQIGMG | 886 | Q6VAB6 | |
| KAGRVPSGAMKMPTM | 216 | P56270 | |
| MQMALKPGGSIRPGM | 716 | Q9HAQ2 | |
| FMPPRMKMDRDPLGG | 356 | P78344 | |
| GMGPRMVNLSECMDP | 311 | O95352 | |
| MTKSNGEEPKMGGRM | 1 | P43003 | |
| MMGEQAPRMGLALPG | 1276 | O00512 | |
| MGAQLRGPMDVQDPM | 576 | Q86UU0 | |
| KRSMGMQRPLGMAGS | 686 | Q86UU0 | |
| RQMDPAMFPGQMAGG | 716 | Q86UU0 | |
| MSQKMRGPGDLMGPQ | 796 | Q86UU0 | |
| SGVMGGPQKMLMPSQ | 826 | Q86UU0 | |
| PQQHLMGKAMAGRMG | 1276 | Q86UU0 | |
| MQAPGRGPLGLRLMM | 1 | Q8IUK8 | |
| SKEPQRGMGFMPKRG | 311 | Q6QEF8 | |
| MEFQGPMPAGMLIER | 121 | Q13751 | |
| PMQKMRGDVFSPPGM | 276 | A4D0S4 | |
| MMGLGNGRRSMKSPP | 1 | Q8NBJ4 | |
| VPGGVGPMTVAMLMQ | 271 | P11586 | |
| MLKHGRAGVPMEVMG | 41 | O00487 | |
| MLGAMFRAGTPMPPN | 1 | Q693B1 | |
| QGHPNMGGPMQRMTP | 166 | P81877 | |
| MGGPMQRMTPPRGMV | 171 | P81877 | |
| APPCMMHSRAMGRGK | 306 | Q9GZM7 | |
| MNVIGRMSFQLPGGM | 86 | Q96NB2 | |
| QMSQGPIAMQAGIPM | 71 | Q9UMZ2 | |
| KQPMLGGNPRMMDSQ | 881 | Q9Y6Q9 | |
| MLQMRPGEIPMGMGA | 981 | Q9Y6Q9 | |
| PRQQGMMGGMHQKES | 701 | P0CG39 | |
| QMAVQGKRPMPGMQQ | 201 | P51532 | |
| MPEHNPGQMGGTMRL | 436 | P17812 | |
| MQEQDMPFLRGGPGM | 2576 | O75592 | |
| GRWMGKDGQQKQMPM | 4246 | O75592 | |
| GSMMPGQHMPGRMIP | 1021 | Q92922 | |
| MSPGNRMPMAGLQVG | 76 | Q92925 | |
| IMGGMGFMKEPGVER | 436 | P49748 | |
| GLGNMGNPMAKNLMK | 46 | P31937 | |
| RPNGGRLPMKVALMM | 186 | Q9Y471 | |
| PQTAMEMLMQGRPGK | 336 | Q96AJ1 | |
| PINGPKEQMGMPMGR | 426 | Q15596 | |
| NMAMMGGPAPSLKQT | 316 | P0CB48 | |
| GEPKEGGMPMNISIM | 26 | Q7Z6J8 | |
| GGMPMNISIMPSSLQ | 31 | Q7Z6J8 | |
| MGMPNMKPGHLMGDP | 246 | O00534 | |
| PMSGQPMGSQMALLA | 71 | O15090 | |
| MRGGKPMPLLACTMA | 106 | P18405 | |
| GPRKMSVIVPGMNMV | 381 | P50607 | |
| PNPMENKGMPFGMGL | 386 | Q9UPQ9 | |
| MIPKEQKGPVMAAMG | 1 | Q8TDC0 |